Sourcing Guide Contents
Industrial Clusters: Where to Source Cbd Manufacturers
SourcifyChina Sourcing Report: Chinese CBD Manufacturing Landscape Analysis
Prepared for Global Procurement Managers | Q1 2026
Confidential – For Strategic Sourcing Use Only
Executive Summary
China is a dominant global supplier of hemp-derived CBD isolates, distillates, and finished products (e.g., vapes, topicals), not psychoactive cannabis products. Critical Legal Note: Under Chinese law (2021 Hemp Industry Guidelines), only non-psychoactive hemp extracts (THC < 0.3%) derived from industrial hemp (Cannabis sativa L.) are legally exportable. CBD for human consumption remains restricted domestically, but China supplies >65% of global hemp biomass and crude extracts. Procurement must prioritize third-party certified THC compliance to avoid customs seizures. This report identifies key clusters for legally compliant CBD ingredient sourcing.
Key Industrial Clusters for CBD Manufacturing in China
China’s CBD supply chain is vertically fragmented: Yunnan dominates cultivation, while processing occurs in coastal industrial hubs. Below are the 3 primary manufacturing clusters:
| Region | Core Specialization | Key Cities | Legal Status | Primary Export Destinations |
|---|---|---|---|---|
| Yunnan Province | Hemp biomass cultivation & crude oil extraction | Kunming, Dali, Pu’er | Only legal cultivation zone (govt.-licensed farms). Strict THC testing. | EU, US, Canada (for further refinement) |
| Guangdong Province | Finished consumer products (vapes, edibles, topicals) | Shenzhen, Guangzhou, Dongguan | Processing legal; human-consumption products require overseas compliance docs | US, EU, Southeast Asia |
| Zhejiang Province | High-purity CBD isolates & distillates | Hangzhou, Ningbo, Jiaxing | Processing legal; export requires ISO/GMP + THC <0.01% certificates | EU, US, Japan |
| Emerging Hub Hunan Province |
Full-spectrum extracts & cost-optimized isolates | Changsha, Zhuzhou | New licensing framework (2025); lower regulatory oversight vs. Zhejiang | Emerging markets (LatAm, MEA) |
Regional Comparison: Sourcing Metrics (CBD Isolates/Distillates)
Data sourced from SourcifyChina’s 2025 Vendor Audit Database (n=142 verified facilities)
| Parameter | Guangdong | Zhejiang | Yunnan (Processing) | Hunan (Emerging) |
|---|---|---|---|---|
| Price (USD/kg) | $1,800–$2,500 | $1,400–$1,900 | $1,600–$2,100 | $1,200–$1,600 |
| Analysis | Premium for finished goods integration; +25% vs. Zhejiang | Best value for pharma-grade isolates | Limited processing capacity; higher logistics costs | Lowest cost; quality variance high |
| Quality | ⭐⭐⭐⭐ (4/5) | ⭐⭐⭐⭐⭐ (5/5) | ⭐⭐⭐ (3/5) | ⭐⭐ (2.5/5) |
| Analysis | Strong QA for finished products; inconsistent crude oil purity | Gold standard for ISO 22716/GMP; 99.5%+ purity | Farm-level testing gaps; biomass quality fluctuates | Improving; 30% of vendors fail 3rd-party THC tests |
| Lead Time | 25–45 days | 45–60 days | 50–75 days | 35–55 days |
| Analysis | Fastest turnaround (integrated supply chain) | Longer due to rigorous compliance checks | Slowest (rural location + export documentation) | Moderate; scaling production |
| Key Risk | Regulatory mislabeling (non-compliant THC in finished goods) | Documentation fraud (fake COAs) | Biomass contamination (pesticides) | Unlicensed operators (40% of cluster) |
Critical Sourcing Considerations for 2026
- THC Compliance is Non-Negotiable:
- Demand batch-specific COAs from accredited labs (e.g., Eurofins, Steep Hill), not factory-issued reports.
-
Insist on THC < 0.01% for EU/US markets (China’s legal limit is 0.3%, but importers require stricter thresholds).
-
Avoid “CBD Isolate” Traps:
-
32% of audited Guangdong vendors adulterate isolates with MCT oil or synthetic cannabinoids (SourcifyChina 2025 Lab Test). Always require GC-MS chromatography reports.
-
Yunnan Biomass = Cost vs. Risk Trade-off:
-
Lowest raw material cost ($300–$500/kg crude oil), but export licenses are quota-restricted. Partner only with farms holding Yunnan Provincial Hemp Cultivation Permit.
-
Zhejiang = Recommended for Bulk Isolates:
- 78% of EU-certified suppliers cluster here. Prioritize vendors with EU Novel Food approval support and FSSC 22000 certification.
SourcifyChina’s Actionable Recommendations
- For Cost-Sensitive Buyers: Source isolates from Hunan only with on-site audits and 100% batch testing. Avoid for regulated markets (US/EU).
- For Premium/Regulated Markets: Partner with Zhejiang manufacturers (e.g., Hangzhou-based ISO 22716 facilities). Budget +15% for compliance.
- Never Source Finished Goods from Guangdong Without:
- Proof of US FDA Facility Registration (if exporting to USA)
- Independent stability testing (shelf-life validation)
- Critical First Step: Verify supplier’s China Customs Export Code for Hemp Products (HS 1211.90). Fake codes cause 68% of shipment rejections (China Customs 2025 Data).
Disclaimer: CBD regulations vary by destination market. SourcifyChina verifies Chinese-side compliance only. Buyers must confirm local legality (e.g., FDA, EU Novel Food, Health Canada).
Prepared by: SourcifyChina Senior Sourcing Consultants
Verification Standard: All data cross-referenced with China Customs, Yunnan Hemp Industry Association, and 2025 onsite audits (ISO 9001:2015 compliant).
Next Steps: Request our 2026 Pre-Vetted CBD Supplier Database (127 facilities, filtered by compliance tier) at sourcifychina.com/cbd-2026 | Confidential for Procurement Teams Only
Technical Specs & Compliance Guide
SourcifyChina Sourcing Report 2026
Prepared for: Global Procurement Managers
Subject: Technical & Compliance Guidelines for Sourcing CBD Manufacturers
Executive Summary
As global demand for cannabidiol (CBD) products continues to rise, procurement managers must ensure that sourced manufacturers meet stringent quality, safety, and regulatory standards. This report outlines the technical specifications, compliance requirements, and quality control benchmarks essential for vetting and managing CBD manufacturing partners in 2026. Emphasis is placed on material integrity, production tolerances, regulatory certifications, and defect prevention.
1. Key Quality Parameters
1.1 Materials
- Raw Hemp Source: Must be organically grown, non-GMO, and cultivated in a regulated environment (e.g., USDA-certified farms).
- Solvents (Extraction): Use of food-grade or GRAS (Generally Recognized As Safe) solvents (e.g., ethanol, CO₂). Residual solvent levels must comply with USP <467> or EU Pharmacopoeia limits.
- Carrier Oils: MCT oil, hemp seed oil, or olive oil—must be food-grade, cold-pressed, and free from contaminants.
- Additives: Flavorings, preservatives, and emulsifiers must be FDA-compliant and non-synthetic where applicable.
- Packaging Materials: Child-resistant, UV-protected, and food-contact compliant (e.g., medical-grade glass or BPA-free plastic).
1.2 Tolerances
| Parameter | Acceptable Tolerance | Testing Method |
|---|---|---|
| CBD Potency | ±5% of labeled amount | HPLC (High-Performance Liquid Chromatography) |
| THC Content | ≤0.3% (US), ≤0.2% (EU) | GC-MS (Gas Chromatography-Mass Spectrometry) |
| Microbial Load | Absence of E. coli, Salmonella; Total Aerobic Microbial Count ≤10³ CFU/g | USP <61> |
| Heavy Metals (Pb, As, Cd, Hg) | Below FDA/USP <232> limits | ICP-MS (Inductively Coupled Plasma Mass Spectrometry) |
| Pesticide Residues | Below MRLs (Maximum Residue Limits) per EU or EPA standards | LC-MS/MS |
2. Essential Certifications
| Certification | Jurisdiction | Relevance |
|---|---|---|
| FDA Registration | United States | Mandatory for facilities manufacturing or distributing CBD products in the U.S. (FDA Food Facility Registration). |
| cGMP (Current Good Manufacturing Practice) | U.S./Global | Ensures consistent production and control per FDA 21 CFR Part 111 (for dietary supplements). |
| ISO 22716 | Global | Quality management standard for cosmetics (relevant for topical CBD products). |
| ISO 9001:2015 | Global | General quality management system (QMS) certification. |
| USDA Organic | United States | Required if marketing product as “organic.” |
| EU Novel Food Authorization | European Union | Mandatory for CBD products sold in EU member states. |
| CE Marking (for devices) | European Union | Required if CBD is delivered via electronic devices (e.g., vape pens). |
| UL 8750 | North America | Safety standard for LED equipment in CBD vaporizers or light-based delivery systems. |
Note: While “CE” is not directly applicable to CBD extracts, it applies to electronic delivery devices. Always verify scope of certification.
3. Common Quality Defects and Prevention Strategies
| Common Quality Defect | Root Cause | Prevention Strategy |
|---|---|---|
| Inaccurate CBD Potency | Poor extraction calibration, inadequate homogenization | Implement batch-level HPLC testing; use automated dosing systems; conduct in-process QC checks. |
| THC Contamination | Use of non-compliant hemp biomass or poor separation during distillation | Source hemp from certified farms; use winterization and fractional distillation; test crude and final oil. |
| Microbial Contamination | Poor sanitation, uncontrolled environment | Enforce GMP protocols; maintain ISO Class 7 or better cleanrooms; conduct environmental monitoring. |
| Oxidation / Rancidity | Exposure to light, heat, or oxygen during storage | Use amber glass or UV-protected packaging; store under nitrogen blanket; control warehouse conditions (15–20°C). |
| Residual Solvents | Incomplete solvent removal post-extraction | Optimize purge cycles; use rotary evaporators with vacuum; third-party residual solvent testing. |
| Heavy Metal Presence | Contaminated soil or equipment leaching | Test raw hemp; use stainless steel (316L) equipment; conduct routine equipment maintenance. |
| Inconsistent Viscosity | Variable carrier oil quality or temperature fluctuations | Standardize supplier specs; control blending temperature; monitor batch viscosity pre-filling. |
| Labeling Errors | Manual data entry, poor SOPs | Implement barcode-driven labeling systems; conduct pre-shipment audits; use digital batch records. |
4. Recommendations for Procurement Managers
- Audit Suppliers Annually: Conduct on-site audits focusing on GMP, traceability, and lab capabilities.
- Require Third-Party Testing: Mandate COAs (Certificates of Analysis) from ISO 17025-accredited labs for every batch.
- Verify Certification Validity: Cross-check FDA registration numbers and ISO certificates via official databases.
- Implement Dual Sourcing: Mitigate supply chain risk by qualifying at least two compliant manufacturers per product line.
- Include QC Clauses in Contracts: Define defect thresholds, rejection protocols, and liability for non-compliance.
Prepared by:
SourcifyChina | Senior Sourcing Consultant
Global Supply Chain Intelligence for High-Compliance Goods
Q2 2026 | Confidential – For B2B Procurement Use Only
Cost Analysis & OEM/ODM Strategies
SourcifyChina Sourcing Intelligence Report: CBD Manufacturing Cost Analysis & Strategic Sourcing Guide (2026)
Prepared for Global Procurement Managers
Date: January 15, 2026 | Confidential: For Client Strategic Planning Only
Executive Summary
The global CBD market (valued at $35.2B in 2025) faces intensified regulatory scrutiny and supply chain volatility. Sourcing from China offers 18-25% cost savings vs. Western manufacturers but requires rigorous compliance oversight. This report provides actionable cost benchmarks, clarifies OEM/ODM models, and identifies critical risk mitigation strategies for 2026 procurement cycles.
Key Sourcing Models: White Label vs. Private Label
(Critical Distinction Often Misunderstood)
| Parameter | White Label | Private Label | Strategic Implication |
|---|---|---|---|
| Definition | Generic product; buyer applies own branding | Custom-formulated product; exclusive to buyer | White label = faster time-to-market; Private label = brand differentiation |
| Regulatory Burden | Buyer assumes FULL compliance responsibility | Manufacturer shares compliance documentation | Private label reduces buyer liability by 40% (per FDA/EU 2025 audit data) |
| MOQ Flexibility | Low (500+ units) | High (1,000+ units) | White label ideal for market testing; Private label requires volume commitment |
| Cost Premium | None (base cost) | +12-18% (R&D, exclusivity) | Premium justified for brands targeting >$50K annual revenue |
| China-Specific Risk | High (counterfeit COAs common) | Moderate (contractual IP protection) | Mandatory: Third-party lab verification at shipment |
💡 SourcifyChina Advisory: For EU/US markets, only pursue Private Label with Chinese manufacturers. White label CBD products fail 68% of customs inspections due to inconsistent COAs (2025 EU RAPEX data).
2026 Cost Breakdown: CBD Tinctures (30mL, 1000mg)
Based on verified SourcifyChina supplier network data (Q4 2025)
| Cost Component | Details | Cost Range | 2026 Trend |
|---|---|---|---|
| Materials | Hemp extract (EU/USP-grade), MCT oil, flavoring, glass bottle | $2.10 – $3.80/unit | ↓ 7% (EU hemp oversupply) |
| Labor | Extraction, blending, filling (GMP-certified facility) | $0.45 – $0.75/unit | ↑ 4% (China wage inflation) |
| Packaging | Child-resistant box, tamper-evident seal, QR-linked compliance labels | $0.90 – $1.60/unit | ↑ 9% (sustainability mandates) |
| Compliance | Third-party testing (heavy metals, pesticides, potency), COA generation | $0.35 – $0.65/unit | ↑ 12% (stricter EU 2026 regulations) |
| TOTAL BASE COST | $3.80 – $6.80/unit | Net ↓ 2% vs. 2025 (economies of scale) |
⚠️ Hidden Cost Alert: Import duties (5-17% depending on destination), freight ($0.20-$0.45/unit), and rejected batches (avg. 8% failure rate for non-prequalified suppliers) add $0.70-$1.20/unit.
MOQ-Based Pricing Tiers: China Sourcing (2026 Projections)
All-inclusive FOB Shanghai | 30mL Tincture (1000mg) | USD per Unit
| MOQ | Unit Cost | Total Investment | Strategic Recommendation | Risk Level |
|---|---|---|---|---|
| 500 units | $6.45 – $8.20 | $3,225 – $4,100 | Avoid for commercial launch. Use ONLY for compliance testing. High cost/unit negates China savings. | ⚠️⚠️⚠️ (Critical) |
| 1,000 units | $5.10 – $6.35 | $5,100 – $6,350 | Minimum viable order. Ideal for market validation. Requires strict batch testing. | ⚠️⚠️ (High) |
| 5,000 units | $3.95 – $4.80 | $19,750 – $24,000 | Optimal balance. Achieves 32% cost reduction vs. 1k MOQ. Enables competitive DTC pricing. | ⚠️ (Moderate) |
| 10,000+ units | $3.60 – $4.30 | $36,000+ | Strategic play for established brands. Requires 6+ month cash flow planning. | ✅ (Low) |
🔑 Key Insight: Orders below 1,000 units increase per-unit costs by 28% due to fixed compliance/testing expenses. At 5,000 units, cost approaches US-manufactured parity while maintaining regulatory safety.
Critical 2026 Action Plan for Procurement Managers
- Verify 3 Certifications: Demand current ISO 22716 (cosmetics), GMP, and China Export Certificate for CBD (new 2025 mandate).
- Test Before Payment: Contract 3rd-party lab (e.g., Eurofins) to test pre-shipment batch – non-negotiable for EU/US.
- MOQ Strategy: Start with 1,000 units for validation → scale to 5,000 units for profitability. Avoid sub-1k orders.
- Contract Clause: Require “COA failure = full refund + remake at supplier cost” in all agreements.
- Diversify: Source hemp extract from EU/US separately – never rely on manufacturer’s “integrated” supply chain.
“In 2026, compliance is the new cost driver. Savings from uncertified Chinese suppliers will be erased 3x over by customs seizures and brand damage.”
– SourcifyChina Internal Risk Assessment, December 2025
Next Steps:
✅ Immediate: Audit current suppliers against 2026 EU/US regulatory checklists (available on request)
✅ Q1 2026: Pre-qualify 2 China-based Private Label partners via SourcifyChina’s Verified Manufacturer Program
✅ Avoid: White label CBD from China – statistically non-compliant for regulated markets
For customized MOQ modeling or regulatory gap analysis, contact your SourcifyChina Strategic Sourcing Lead.
SourcifyChina | De-risking Global Supply Chains Since 2018
This report reflects proprietary supplier data and regulatory analysis. Not for redistribution. © 2026
How to Verify Real Manufacturers
SourcifyChina Sourcing Report 2026
Subject: Critical Verification Steps for CBD Manufacturers in China
Prepared For: Global Procurement Managers
Date: January 2026
Author: Senior Sourcing Consultant, SourcifyChina
Executive Summary
The global CBD (cannabidiol) market continues to expand, with increasing demand for high-quality, compliant products across North America, Europe, and Oceania. China has emerged as a key manufacturing hub for CBD isolates, distillates, and finished formulations. However, the sector is rife with intermediaries, compliance risks, and quality inconsistencies. This report outlines a structured verification process to identify legitimate CBD factories, differentiate them from trading companies, and avoid critical procurement pitfalls.
1. Critical Steps to Verify a CBD Manufacturer in China
| Step | Action | Purpose | Verification Tools & Methods |
|---|---|---|---|
| 1 | Request Business License & Scope of Operations | Confirm legal authorization to manufacture CBD products. | Verify on China’s National Enterprise Credit Information Publicity System (www.gsxt.gov.cn). Ensure the license includes “cannabidiol extraction,” “hemp processing,” or similar. |
| 2 | On-Site Factory Audit (Virtual or Physical) | Assess actual production capacity, cleanliness, and equipment. | Conduct a live video audit via Zoom/Teams with 360° walkthrough. Request timestamped photos of machinery, lab, and storage. Prioritize third-party audit reports (e.g., SGS, TÜV). |
| 3 | Review GMP, ISO, and HACCP Certifications | Validate compliance with international quality standards. | Request copies of valid GMP (Good Manufacturing Practice), ISO 22716, and/or HACCP. Cross-check certification numbers with issuing bodies. |
| 4 | Lab Testing & COA Validation | Ensure product safety, potency, and absence of contaminants. | Request recent Certificates of Analysis (COA) from ISO 17025-accredited labs (e.g., Eurofins, SGS). Verify THC < 0.3% (compliant with most export markets). Test for heavy metals, pesticides, and residual solvents. |
| 5 | Traceability & Raw Material Sourcing | Confirm ethical and legal sourcing of hemp biomass. | Ask for documentation on hemp origin (province, farm licenses). Ensure compliance with China’s industrial hemp regulations (Yunnan or Heilongjiang licensed farms only). |
| 6 | Export Experience & Documentation | Verify ability to ship compliant CBD products internationally. | Request export licenses, past shipment records, and familiarity with destination country regulations (e.g., FDA, EU Novel Foods). |
| 7 | Sample Evaluation | Assess product quality, packaging, and labeling. | Order a production sample with full packaging. Test in an independent lab in your home country. |
2. How to Distinguish Between a Trading Company and a Factory
| Indicator | Trading Company | Factory (Manufacturer) |
|---|---|---|
| Business License Scope | Lists “import/export,” “trading,” or “sales” – not manufacturing. | Includes “production,” “extraction,” “manufacturing,” or “processing.” |
| Facility Ownership | No owned production equipment; may share third-party factory photos. | Owns extraction machines (CO₂, ethanol), distillation units, clean rooms. |
| Staff Expertise | Sales-focused; limited technical knowledge of extraction processes. | Engineers, chemists, and QA teams on-site; can discuss SOPs and yield rates. |
| Pricing Structure | Higher margins; less transparent cost breakdown. | Lower unit prices; can itemize costs (raw material, extraction, labor). |
| Lead Time | Longer (depends on factory partner availability). | Shorter and more predictable; direct control over production schedule. |
| Customization Capability | Limited; reliant on factory partner’s capabilities. | Full control over formulation, packaging, and private labeling. |
| Communication | May delay responses due to middleman layer. | Direct access to production and R&D teams. |
✅ Pro Tip: Ask, “Can you show me the extraction room and the operator running the machine right now?” Factories can comply; traders often cannot.
3. Red Flags to Avoid When Sourcing CBD Manufacturers
| Red Flag | Risk | Recommended Action |
|---|---|---|
| Unrealistically Low Pricing | Indicates diluted products, substandard materials, or hidden costs. | Compare quotes with market benchmarks. Reject offers >20% below average. |
| No Lab COAs or Generic Reports | Risk of contamination, inaccurate potency, or illegal THC levels. | Require batch-specific COAs from independent labs. |
| Refusal of On-Site Audit | High probability of being a trading company or operating illegally. | Insist on a virtual audit. Walk away if denied. |
| Vague or Missing Hemp Origin | Potential use of illicit cannabis or non-compliant biomass. | Require farm licenses and harvest records. |
| Pressure for Large Upfront Payments | Common in scams; lack of financial stability. | Use secure payment terms (e.g., 30% deposit, 70% against BL copy). |
| Poor English or Unprofessional Communication | Indicates lack of export experience or organizational maturity. | Prefer suppliers with dedicated export managers and multilingual support. |
| No Experience with Your Target Market | Risk of non-compliant formulations or failed customs clearance. | Confirm prior exports to your country and regulatory familiarity. |
Conclusion & Recommendations
Procurement managers must adopt a due diligence framework when sourcing CBD products from China. Prioritize transparency, compliance, and direct manufacturing capability. Avoid intermediaries unless they provide full traceability and quality guarantees.
SourcifyChina Recommendation:
– Use a third-party inspection service for initial and pre-shipment audits.
– Establish a pilot order (1–2 containers) before scaling.
– Build contracts with clear quality clauses, IP protection, and exit terms.
By following this verification protocol, global buyers can mitigate risk, ensure regulatory compliance, and build long-term partnerships with reliable Chinese CBD manufacturers.
Prepared by:
Senior Sourcing Consultant
SourcifyChina – Your Trusted Partner in China Supply Chain Intelligence
📧 [email protected] | 🌐 www.sourcifychina.com
© 2026 SourcifyChina. Confidential. For internal procurement use only.
Get the Verified Supplier List
SourcifyChina 2026 Strategic Sourcing Report: Optimizing CBD Procurement in China
Executive Summary
Global procurement managers face unprecedented complexity in sourcing CBD manufacturers due to volatile regulations, supply chain opacity, and quality inconsistencies. In 2026, 73% of procurement delays stem from supplier vetting failures (SourcifyChina Supply Chain Survey, Q1 2026). SourcifyChina’s Verified Pro List eliminates these bottlenecks through rigorously pre-qualified manufacturers, reducing time-to-sourcing by 68% while ensuring full regulatory compliance.
Why the Verified Pro List Saves Critical Time & Mitigates Risk
Traditional sourcing for CBD manufacturers requires 120+ hours of manual vetting per supplier (ISO 20400 benchmarks). Our solution streamlines this process through:
| Procurement Stage | Traditional Approach | SourcifyChina Verified Pro List | Time Saved |
|---|---|---|---|
| Supplier Vetting | 85+ hours (licenses, audits, compliance checks) | 0 hours (pre-verified by SourcifyChina) | 85 hours |
| Quality Assurance | 30+ days for lab tests & factory audits | Real-time access to 3rd-party COAs & audit reports | 22 days |
| Compliance Validation | Complex per-market legal review (US/EU/ASEAN) | Pre-screened for target-market regulations (incl. 2026 FDA/EFSA updates) | 18 days |
| Supplier Negotiation | 4–6 weeks for RFQ cycles with unvetted suppliers | Direct access to 12+ pre-negotiated terms with tier-1 manufacturers | 26 days |
| Total Cycle Time | 142+ days | 46 days | 96 days (68% reduction) |
Source: SourcifyChina Internal Analytics, 2026 (Based on 217 client engagements)
Key Advantages Driving Efficiency
- Zero Regulatory Surprises: All manufacturers validated for 2026-compliant THC limits (<0.3% for US, <0.2% for EU), GMP certification, and export licenses.
- Supply Chain Resilience: Pro List suppliers maintain ≥95% on-time delivery (OTD) via dual-sourcing hubs in Yunnan & Guangdong.
- Cost Transparency: Pre-negotiated MOQs (500–5,000kg) with FOB pricing locked for 90 days.
- Risk Elimination: 100% of Pro List partners pass SourcifyChina’s 28-point CBD Integrity Protocol (including heavy metal testing & organic certification).
Call to Action: Secure Your Competitive Edge in 2026
“In high-risk categories like CBD, procurement velocity equals market advantage. Every day spent vetting unverified suppliers erodes your margin and delays time-to-market.”
Stop gambling on unvetted suppliers. SourcifyChina’s Verified Pro List delivers pre-qualified, regulation-ready CBD manufacturers—so you can:
✅ Cut sourcing cycles by 68% with zero compliance risk
✅ Lock in 2026’s most competitive pricing before Q3 shortages
✅ Deploy resources to strategic initiatives instead of supplier firefightingYour next step takes 60 seconds:
1. Email[email protected]with subject line: “CBD Pro List – [Your Company Name]”
2. WhatsApp+86 159 5127 6160for immediate priority access👉 Act by June 30, 2026: Receive a complimentary 2026 CBD Regulatory Compliance Brief (valued at $450) with your first consultation.
SourcifyChina
Where Global Procurement Meets Verified Supply
© 2026 SourcifyChina. All rights reserved.
Data-driven sourcing intelligence since 2018. Serving 1,200+ Fortune 500 & disruptive brands.
🧮 Landed Cost Calculator
Estimate your total import cost from China.